Shanghai MicroPort Endovascular MedTech Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003MJ5
CNY
92.00
-0.15 (-0.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Why is Shanghai MicroPort Endovascular MedTech Co., Ltd. ?
1
Negative results in Mar 25
  • NET PROFIT(HY) At CNY 78.4 MM has Grown at -72.81%
  • INTEREST(HY) At CNY 1.44 MM has Grown at 74.9%
  • OPERATING CASH FLOW(Y) Lowest at CNY 230.91 MM
2
With ROE of 10.02%, it has a expensive valuation with a 3.25 Price to Book Value
  • Over the past year, while the stock has generated a return of -10.68%, its profits have fallen by -33.7%
  • At the current price, the company has a high dividend yield of 1.1
3
Below par performance in long term as well as near term
  • Along with generating -10.68% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai MicroPort Endovascular MedTech Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.68%
-0.46
34.27%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
24.57%
EBIT Growth (5y)
17.79%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.38
Tax Ratio
25.31%
Dividend Payout Ratio
48.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
74.02%
ROE (avg)
16.77%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
3.25
EV to EBIT
28.54
EV to EBITDA
23.60
EV to Capital Employed
5.97
EV to Sales
9.68
PEG Ratio
NA
Dividend Yield
1.11%
ROCE (Latest)
20.91%
ROE (Latest)
10.02%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NO KEY POSITIVE TRIGGERS
-29What is not working for the Company
NET PROFIT(HY)

At CNY 78.4 MM has Grown at -72.81%

INTEREST(HY)

At CNY 1.44 MM has Grown at 74.9%

OPERATING CASH FLOW(Y)

Lowest at CNY 230.91 MM

NET SALES(HY)

At CNY 563.74 MM has Grown at -13.3%

ROCE(HY)

Lowest at 11.34%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.58%

RAW MATERIAL COST(Y)

Grown by 7.8% (YoY

Here's what is not working for Shanghai MicroPort Endovascular MedTech Co., Ltd.
Net Profit
At CNY 78.4 MM has Grown at -72.81%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest
At CNY 1.44 MM has Grown at 74.9%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 563.74 MM has Grown at -13.3%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Debtors Turnover Ratio
Lowest at 3.58% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Cash Flow
Lowest at CNY 230.91 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Raw Material Cost
Grown by 7.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales